Tyloxapol
Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type that acts as a mucolytic and surfactant, reducing surface tension in respiratory secretions to facilitate mucociliary clearance. It is used as a respiratory adjunct to thin and mobilize viscous bronchial secretions in conditions such as bronchitis, asthma, and postoperative atelectasis. It has also been used as a pharmaceutical excipient to disperse poorly water-soluble substances.
Etki Mekanizması
Reduces surface tension at the air-liquid interface in the pulmonary alveoli, preventing alveolar collapse during expiration and improving lung compliance and gas exchange.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Reduces surface tension at the air-liquid interface in the pulmonary alveoli, preventing alveolar collapse during expiration and improving lung compliance and gas exchange.
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
Tyloxapol is a nonionic liquid polymer of the alkyl aryl polyether alcohol type that acts as a mucolytic and surfactant, reducing surface tension in respiratory secretions to facilitate mucociliary clearance. It is used as a respiratory adjunct to thin and mobilize viscous bronchial secretions in conditions such as bronchitis, asthma, and postoperative atelectasis. It has also been used as a pharmaceutical excipient to disperse poorly water-soluble substances.
Reduces surface tension at the air-liquid interface in the pulmonary alveoli, preventing alveolar collapse during expiration and improving lung compliance and gas exchange.
Yes, Tyloxapol is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201548. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="tyloxapol"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/tyloxapol/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/tyloxapol/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/tyloxapol/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="tyloxapol"></drugfyi-drug>